Display Options:
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cyclooxygenase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Colorectal Neoplasms, Hereditary Nonpolyposis; Distal Myopathies; Alzheimer Disease; Breast Neoplasms; Duodenal Ulcer; Neuralgia; Pleural Effusion; Prostatic Neoplasms; Wounds and Injuries; Low Back Pain; Migraine Disorders; Multiple Sclerosis; Osteoarthritis, Hip; Osteoarthritis, Knee; Peptic Ulcer; Severe Acute Respiratory Syndrome; Acute Pain; Arthralgia; Arthritis; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid; Back Pain; Bursitis; Common Cold; Dysmenorrhea; Fever; Gout; Headache; Muscle Cramp; Myalgia; Osteoarthritis; Pain; Rheumatic Diseases; Spondylitis; Spondylitis, Ankylosing; Stomach Ulcer; Tendinopathy; Toothache; Vaginitis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: D2-like dopamine receptor antagonist
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Bone Neoplasms; Breast Neoplasms; Glioma; Kidney Neoplasms; Neoplasm Metastasis; Sarcoma; Lung Neoplasms; Lymphoma; Lymphoma, AIDS-Related; Melanoma; Astrocytoma; Central Nervous System Neoplasms; Glioblastoma; Gliosarcoma; Leukemia, Myeloid, Acute; Medulloblastoma; Multiple Myeloma; Brain Neoplasms; Hodgkin Disease; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Androgen Receptor agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Anemia, Aplastic; Dyskeratosis Congenita; Fanconi Anemia; Endometrial Neoplasms; Mastodynia; Myelodysplastic Syndromes; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; Infertility; Endometriosis; Fibrocystic Breast Disease
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hemorrhoids; Pruritus
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Mu opioid receptor agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Diarrhea
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Arthralgia; Myalgia; Rheumatic Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Intestinal Obstruction; Breast Neoplasms; Clostridium Infections; Eczema; Neoplasms; Paget Disease, Extramammary; Carcinoma, Non-Small-Cell Lung; Diarrhea; Fecal Incontinence
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cell membrane inhibitor
ROUTE OF ADMINISTRATION: DENTAL; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Head and Neck Neoplasms; Abscess; Candidiasis, Vulvovaginal; Clostridium Infections; Cystic Fibrosis; HIV Infections; Mucositis; Radiodermatitis; Sepsis; Severe Acute Respiratory Syndrome; Stomatitis; Acanthamoeba Keratitis; Dental Caries; Infections; Peri-Implantitis; Pneumonia; Gingivitis; Periodontitis; Pharyngitis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Rheumatic Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Myocardial Infarction; ST Elevation Myocardial Infarction
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Ectoparasitic Infestations
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hyperthyroidism; Thyroid Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-A receptor; anion channel positive modulator
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Disclosing agent
ROUTE OF ADMINISTRATION: INJECTION; INTRAVENOUS
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Heart Septal Defects, Ventricular; Neurilemmoma; Skin Diseases; Hyperemia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Breast Neoplasms; Neoplasms; Hyperemia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial penicillin-binding protein inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Sepsis; Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Radioactive metals chelating agent
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Sepsis; Infections; Bacterial Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Burns; Hemorrhoids; Inflammation; Pruritus; Sunburn
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dopamine transporter inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Obesity
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Progesterone receptor agonist
ROUTE OF ADMINISTRATION: INJECTION; INTRAUTERINE; ORAL; VAGINAL
STATUS: Approved
THERAPEUTIC AREA: DIABETES DRUGS & ENDOCRINOLOGY; OTHER; PREGNANCY AND GYNECOLOGY
THERAPEUTIC INDICATION: Diabetes Mellitus, Type 1; Anorexia Nervosa; Bulimia Nervosa; Cervical Intraepithelial Neoplasia; Cocaine-Related Disorders; Coronary Disease; Depression, Postpartum; Endometrial Neoplasms; HIV Infections; Marijuana Abuse; Orthostatic Intolerance; Placenta Previa; Polycystic Ovary Syndrome; Pre-Eclampsia; Severe Acute Respiratory Syndrome; Tobacco Use Disorder; Vulvar Lichen Sclerosus; Alzheimer Disease; Angina, Unstable; Bone Diseases, Metabolic; Brain Injuries; Breast Neoplasms; Diabetes Mellitus; Epilepsy; Hypercholesterolemia; Hypertension; Infertility; Infertility, Female; Leiomyoma; Memory Disorders; Menopause; Myocardial Ischemia; Osteoporosis; Ovarian Hyperstimulation Syndrome; Ovarian Neoplasms; Pregnancy; Premature Birth; Thrombosis; Amenorrhea; Endometrial Hyperplasia; Uterine Hemorrhage
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Colonic bacteria substrate
ROUTE OF ADMINISTRATION: ORAL; RECTAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Premature Birth; Dermatitis, Atopic; Liver Cirrhosis; Brain Diseases; Constipation
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cyclooxygenase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Arthritis, Rheumatoid; Osteoarthritis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Acanthamoeba Keratitis; Diabetic Foot; Neonatal Sepsis; Peri-Implantitis; Periodontal Diseases; Pneumonia, Ventilator-Associated; Pulmonary Disease, Chronic Obstructive; Severe Acute Respiratory Syndrome; Stomatitis; Bacteremia; Bacterial Infections; Communicable Diseases; Dental Caries; Gingivitis; Neutropenia; Periodontitis; Pharyngitis; Pneumonia; Staphylococcal Infections; Eye Infections; Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INHALATION; NASAL
STATUS: Approved
THERAPEUTIC AREA: IMMUNE SYSTEM; OTHER; RESPIRATORY
THERAPEUTIC INDICATION: Enteritis; Eosinophilic Esophagitis; Infections; Folliculitis; Idiopathic Pulmonary Fibrosis; Nasal Polyps; Severe Acute Respiratory Syndrome; Small Cell Lung Carcinoma; Bronchiectasis; Bronchopulmonary Dysplasia; Croup; Graft vs Host Disease; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome, Newborn; Sinusitis; Asthma; Lung Diseases, Obstructive; Nasal Obstruction; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Human herpesvirus 1 DNA polymerase inhibitor
ROUTE OF ADMINISTRATION: INJECTION; OPHTHALMIC
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Herpes Simplex; Eye Infections; Virus Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Anxiety; Substance Withdrawal Syndrome; Urinary Bladder, Neurogenic; Amphetamine-Related Disorders; Severe Acute Respiratory Syndrome; Tobacco Use Disorder; Alcoholism; Kidney Calculi; Stress Disorders, Post-Traumatic; Hypertension
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Adrenergic receptor agonist
ROUTE OF ADMINISTRATION: INHALATION; INJECTION; INTRAMUSCULAR; INTRAOCULAR; INTRAVENOUS; SUBCUTANEOUS
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Anaphylaxis; Chronic Pain; Infections; Tachypnea; Acute Lung Injury; Appendicitis; Breast Neoplasms; Cognitive Dysfunction; Death, Sudden, Cardiac; Hemoptysis; Hypospadias; Hypotension; Musculoskeletal Diseases; Osteoarthritis, Knee; Rotator Cuff Injuries; Shock; Tachycardia, Ventricular; Ventricular Fibrillation; Wounds and Injuries; Bronchiolitis; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Hemorrhage; Genital Neoplasms, Male; Heart Failure; Myoma; Osteoarthritis; Pain; Pulpitis; Rhinitis, Allergic, Perennial; Stomach Neoplasms; Angioedema; Asthma; Bronchial Spasm; Cardiovascular Diseases; Glaucoma; Heart Arrest; Hemorrhage; Hypersensitivity; Lung Diseases, Obstructive; Muscle Cramp; Mydriasis; Nasal Obstruction; Rhinitis, Allergic, Seasonal; Serum Sickness; Shock, Septic; Sinusitis; Urticaria